Press Release: Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Meeting

Pratteln, Switzerland, November 29, 2022 -- Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Extraordinary General Meeting (EGM) held today at the Company's domicile in Pratteln, Switzerland. In total, 18,776,400 shares equaling 25.5% of the Company's share capital......
. .
Veröffentlicht von: - Nachrichten Ticker - Tuesday, 29 November
Share |